Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING LLC
GLOBETECH PUBLISHING LLC
PZ HTL SA

Debate Resolved on Human Cell Shut-Down Mechanisms

By BiotechDaily International staff writers
Posted on 25 Apr 2012
Researchers have resolved the controversy over the mechanisms involved in the shutdown process during cell division in the body.

The investigators, from the University of Liverpool (UK), published their findings April 2012 in the journal Proceeding of the National Academy of Sciences of the USA (PNAS), may contribute to future research on how scientists could modify this shut-down process to ensure that viruses and other pathogens do not enter the cells of the body and cause harm.

Earlier studies had shown that when cells divide, they cannot execute any other task apart from this one. They cannot, for example, take in food and fluids at the same time as managing the important process of dividing into “daughter cells” to replicate the body’s genetic data. Instead, cells, shut-down the intake of food and fluid during cell division, and for many years it was thought that they did this by preventing a receptor from moving nutrients through the cell membrane.

Recently, scientists have provided evidence to suggest that this hypothesis may be wrong. Scientists have contended that the cell does not shut down the processes that allow food and fluid to enter the cell as previously believed, but rather the receptors that transport this fuel are absent altogether during cell division, allowing the cell to focus on the one task of dividing.

Studies at Liverpool, however, have now shown that the original concept, first documented in 1965, is accurate. The receptors are present and able to transport food and fluid during cell division, but the mechanism that allows them through the membrane of the cell shuts-down until cell division is complete.

Dr. Stephen Royle, from the University’s Institute of Translational Medicine, explained, “We know that cells in the body do not have the ability to multitask during cell division. It can only focus on the job of dividing and not on other important tasks such as uptake of nutrients. If we think of the cell membrane like a dock at a port and the receptors as a boat delivering cargo, we have shown that the boat, or receptor, is present but the dock, or membrane, does not allow it to unload or go any further. Viruses and pathogens use the same route into cells as nutrients, so the next stage of this work is to identify the trigger for this shutdown process, so that we understand whether this on/off switch can be manipulated to prevent harmful infections passing through the cell membrane. This is a long way in the future, but this work puts us closer to understanding how the cells in the body work.”

Related Links:

University of Liverpool



comments powered by Disqus

Channels

Genomics/Proteomics

view channel
Image: This novel, flexible film that can react to light is a promising step toward an artificial retina (Photo courtesy of the American Chemical Society).

Novel Nanofilm May Be Artificial Retina Precursor

Researchers have used advanced nanotechnology techniques to develop a light-sensitive film that has potential for future artificial retina applications. Investigators at the Hebrew University of Jerusalem... Read more

Drug Discovery

view channel
Image: Disruption and removal of malaria parasites by the experimental drug (+)-SJ733 (Photo courtesy of the University of California, San Francisco).

Experimental Antimalaria Drug Induces the Immune System to Destroy Infected Red Blood Cells

An experimental drug for the treatment of malaria was found to induce morphological changes in infected erythrocytes that enabled the immune system to recognize and eliminate them. Investigators at... Read more

Business

view channel

R&D Partnership Initiated to Reduce Development Time for New Drugs

nanoPET Pharma, GmbH (Berlin, Germany) signed an open-ended framework contract with the international pharmaceutical company Boehringer Ingelheim (Ridgefield, CT, USA). By developing customized contrast agents for research in both basic and preclinical studies, nanoPET Pharma will contribute to the enhancement of Boehringer... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.